Impaired Humoral but Substantial Cellular Immune Response to Variants of Concern B1.1.7 and B.1.351 in Hemodialysis Patients after Vaccination with BNT162b2

J Am Soc Nephrol. 2021 Nov;32(11):2725-2727. doi: 10.1681/ASN.2021050672.
No abstract available

Keywords: COVID-19; SARS-CoV-2; cellular; chronic hemodialysis; clinical immunology; immunity; infectious diseases; kidney disease; mRNA vaccine; vaccination.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral
  • BNT162 Vaccine
  • COVID-19 / prevention & control
  • COVID-19 Vaccines*
  • Case-Control Studies
  • Humans
  • Immunity, Cellular / physiology*
  • Immunity, Humoral / physiology*
  • Renal Dialysis*
  • Renal Insufficiency / immunology*
  • Renal Insufficiency / therapy
  • SARS-CoV-2 / immunology*

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines
  • BNT162 Vaccine